Continue to Site

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » Endo targets American Medical Systems for $2.9 billion | Acquisitions roundup

Endo targets American Medical Systems for $2.9 billion | Acquisitions roundup

By

M and A Roundup

A company that began life in the pharmaceutical sector is venturing forth into devices in its quest to become a more diversified health care company.

Chadds Ford, Pa.-based Endo Pharmaceuticals Holdings Inc. (NSDQ:ENDP) announced that the company is buying Minnetonka-based American Medical Systems Holdings Inc. (NSDQ:AMMD), a manufacturer of medical devices focusing on male and female pelvic health for $30 per share, or $2.9 billion in cash. The deal includes Endo assuming and repaying $312 million of AMS debt.

Endo projected that 2011 revenue for the combined company would be $3 billion with $1 billion in earnings before interest, tax, depreciation and amortization (EBITDA). The acquisition would add about 60 cents per share to Endo’s 2012 adjusted diluted earnings per share once it closes, the company estimated.

The combined company would also have a total of 4,000 employees. AMS employs 1,200 people in nine countries, according to its website. Its first product — an artificial urinary sphincter implant — came out in 1972 and the company went public in 2000.

“Through the acquisition of AMS, we will gain scale in devices and services, and will be positioned as a leading provider of healthcare solutions in the field of pelvic health, with a full spectrum of product offerings ranging from pharmaceuticals to medical devices,” Endo CEO Dave Holveck said in prepared remarks.

In 2010, Endo bought HealthTronics, which makes a full line of urology equipment and products, including lithotripters and surgical lasers for treatment of enlarged prostate (BPH).

The transaction needs to be approved by AMS shareholders and is expected to close in the third quarter of 2011.

AMMD shares rocketed more than 32 percent to close at $29.50, up $7.17 for the day. ENDP shares ended the day up 21 cents, or about a half percent, to close at $41.06.

Here’s a roundup of companies announcing mergers, acquisitions and divestitures.

  • Shrink enters deal to buy Nanopoint
    Shrink Nanotechnologies Inc. (OTC:INKN), an innovative high technology company, announced that it has executed a binding letter of intent to acquire 100 percent of Hawaii-based Nanopoint Inc., a biomedical instrumentation and microfluidics company with global distribution for its award-winning suites of life sciences products.
    Read more

  • MD-IT closes merger deal with MDnetwork
    MD-IT, a provider of medical documentation software and service to ambulatory clinics and physician offices, announced that it has concluded a merger agreement with MDnetwork Inc. Bard Betz CEO of privately-held MDnetwork, joined MD-IT as vice president of channel development, writes EMR Daily News.
    Read more

  • Rochester Medical closes Laprolan acquisition
    Rochester Medical Corp. (NSDQ:ROCM) announced that it has now completed the previously announced purchase of Laprolan B.V., the former Medical Supplies Division and wholly owned subsidiary of Fornix BioSciences N.V. Under the terms of the purchase agreement the purchase is deemed retroactive to January 1.
    Read more

  • CareFusion acquires technology for sorting and managing pharma waste
    CareFusion (NYSE:CFN), a leading global medical technology company, announced it has acquired technology to automate the segregation of pharmaceutical waste, helping hospitals reduce cost, improve regulatory controls and facilitate environmental responsibility.
    Read more

  • LabCorp signs deal to buy Orchid Cellmark
    Laboratory Corporation of America Holdings (NYSE:LH) and Orchid Cellmark Inc. (NSDQ:ORCH), a provider of DNA testing services primarily for forensic and family relationship applications, announced that they have entered into a definitive agreement and plan of merger under which LabCorp will acquire all of the outstanding shares of Orchid Cellmark in a cash tender offer for $2.80 per share for a total purchase price to stockholders and optionholders of approximately $85.4 million.
    Read more

  • Medicomp announces company purchase from United Therapeutics
    Medicomp Inc., previously a wholly-owned subsidiary of United Therapeutics Corporation, announced that it has been acquired by an investment group made up of current and past Medicomp management led by Dr. Dan Balda, Medicomp’s president and CEO.
    Read more

  • CryoLife begins tender offer for Cardiogenesis shares
    CryoLife Inc. (NYSE:CRY), an implantable biological medical device and cardiovascular tissue processing company, announced that it, through its wholly-owned subsidiary CL Falcon Inc., has commenced a cash tender offer for all outstanding shares of Cardiogenesis Corp. (OTC:CGCP) common stock.
    Read more

  • Thermo Fisher closes Athena Diagnostics and Lancaster Labs divestitures
    Thermo Fisher Scientific Inc. (NYSE:TMO) completed the previously announced sales of its two laboratory-testing services businesses, Athena Diagnostics and Lancaster Laboratories, in two separate transactions, resulting in total proceeds of $940 million.
    Read more

Material from MedCity News was used in this report.

In case you missed it

RSS From Medical Design & Outsourcing

  • Johnson Matthey opens medical nitinol facility in Mexico
    Johnson Matthey today opened a brand new nitinol facility in Mexicali, Mexico for its Medical Device Components business. The facility has 40,000 square feet of manufacturing space for nitinol sheet and tubing, double the capacity of the company’s previous location in San Jose, California. The newly constructed plant in Mexicali is the world’s only low-cost-country… […]
  • 5 Black medtech startup founders to know
    Five startup founders are preparing their pitches for the gBETA Medtech Black Founders Accelerator’s virtual showcase next week. Their companies are the eighth cohort for the gBETA Medtech Accelerator, which focused on Black founders for its fall 2022 program. The five companies received $10,000 grants, plus coaching, mentorship and other support over the course of… […]
  • Understanding the design of electromagnetic navigation technology
    As electromagnetic navigation becomes the top choice for surgical navigation, sensor and design considerations are critical. David Bosch, Intricon Since its inception in the 1990s to widespread adoption by the late 2000s, electromagnetic navigation (EMN) has emerged as the clear choice for surgical navigation and has been widely adopted in the fields of interventional bronchoscopy,… […]
  • Mapping epileptic seizures with new brain activity models
    Johns Hopkins University researchers have developed new models for mapping epileptic seizures. The models could help surgeons identify the precise location in the brain where the seizures originate (called “epileptogenic zones”) to improve treatment — and decide whether an operation is worth the risk. “We want surgeries to go well, but we also want to… […]
  • Ekso Bionics buys Indego exoskeletons from Parker Hannifin
    The Indego exoskeleton deal includes all of Parker’s Human Motion and Control business and gives Ekso a new development partner. Ekso Bionics Holdings (Nasdaq:EKSO) has purchased the Indego exoskeleton line and the rest of Parker Hannifin’s Human Motion and Control (HMC) business unit. The $10 million deal includes the planned development of robotic-assisted orthotic and… […]
  • Synopsys updates Simpleware image processing software
    Synopsys has announced version U-2022.12 of its Simpleware image processing software, which is used in life science and advanced materials and manufacturing applications. The Mountain View, California-based company said the new version allows users to easily segment CMF CT scans using Simpleware AS Ortho/CMF, reduce the effort of placing connectors for preparing 3D prints, and… […]
  • The neuroscience of play: What medical device companies can learn from video games
    Device makers can accelerate the development of new skills and treatments for physicians by harnessing the power of video games. Sam Glassenberg, Level Ex Over the past three decades, a growing cohort of economists, psychologists, and designers have been successfully distilling the optimal neurochemical recipe for accelerating product adoption and driving skill development. They’ve been… […]
  • Philips seeks new superconducting materials for helium-free MRI scanners
    Royal Philips and superconducting magnetics researchers will seek ways to develop magnetic resonance imaging (MRI) scanners without helium cooling through a new partnership agreement. Their findings could make MRI scanners smaller, lighter and less expensive to manufacture and operate, increasing patient accessibility. With the world’s limited amount of helium dwindling, suppliers are rationing while medical… […]
  • How Schurter helped Biotronik develop the Renamic Neo
    Biotronik won FDA approval for its Renamic Neo programmer for implanted cardiac rhythm management devices this year, thanks to some help from an electronic components supplier. The Lake Oswego, Oregon-based device developer designed the Renamic Neo for implantable cardioverter defibrillators, pacemakers and implantable cardiac monitors. The control unit wirelessly communicates with the implanted device and… […]
  • Millstone Medical Outsourcing acquires Ethide Labs
    Millstone Medical Outsourcing announced today that it completed its acquisition of regulatory testing services provider Ethide Labs. Fall River, Massachusetts-based Millstone completed its acquisition on Nov. 14, 2022. West Warwick, Rhode Island-based Ethide Labs brings more than 60 years of experience in regulatory testing services for the medical device and pharmaceutical industries. The certified laboratory… […]
  • Irish researchers think their new material could enable better spinal cord repair
    Researchers at the University of Limerick in Ireland shared research demonstrating progress in spinal cord tissue repair. The researchers, who conducted work at UL’s Bernal Institute, published their findings in Biomaterials Research. According to a news release, they developed new hybrid biomaterials. They turned to nanoparticles built on existing practices in tissue engineering. As a… […]

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy